News & Blog

A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants with Friedreich’s Ataxia Aged 2 to 15 Years Old (BRAVE)

Remote Monitoring Study for Friedreich’s Ataxia

TRACK-FA: A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich’s ataxia

NAD+ and Exercise in FA (ExRx in FA) – Nicotinamide Riboside (NR)

Omaveloxolone Dose Finding Study in Children With Friedreich’s Ataxia (BOLD)

Gene Therapy for Cardiomyopathy Associated with Friedreich’s Ataxia – LX2006

A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia

A Randomized, Parallel-Arm, Double-Blind, Placebo-Controlled Study With Open-Label Extension to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Friedreich Ataxia (MOVE-FA)

A Study of Vatiquinone for the Treatment of Participants with Friedreich’s Ataxia

A Pilot Investigator Initiated Study to Evaluate the Safety, Tolerability and Efficacy of Elamipretide in the Treatment of Advanced Symptoms of Friedreich Ataxia (FRDA)

A Double-Blind, Placebo-Controlled, Dose Exploration Study of CTI-1601 in Adult Subjects with Friedreich’s Ataxia – CTI-1601